UNH near significant bottomUNH is correcting the cycle from Mar 2020 and is near a significant bottom. Most likely it will bounce followed by a marginal low. Great generational long opportunity, with stop set at 409.
UNH trade ideas
Good enter pointNYSE:UNH reached 450 $ recently.
From December 2021 never reached bellow this level. It tried 450 $ six times and bounced back to 550 $. From December 2021 NYSE:UNH is is swing in a channel between 450 and 550 $.
In weekly chart, it is on 200 days moving average, which seems a very strong support. From December 2021 it always trades above 200 days moving average. In march 2020 it touched the moving average, however, it bounced back and moved higher.
I believe NYSE:UNH could easily reach 500 $ in near future and 500 $ is not out of reach.
I set my stop loss at 435 $.
Good luck to everybody.
UnitedHealth: Recovery? 🩹UnitedHealth shares have now dipped into the green Target Zone between $447.18 and $470.19. This is the price range in which we expect the low of the green wave (B) and thus a reversal. We therefore now expect a rise to above $495.87. At 40%, however, we think it is likely that the price will slip below the zone again and the low of the green wave alt.(B) will end somewhat lower.
UNH Long?Been stuck in this range for a while. Looks oversold with bullish divergence on the daily chart at the bottom of the range.
Medicare Advantage Rates Shake Health Insurers:The healthcare sector witnessed a significant upheaval as UnitedHealth ( NYSE:UNH ) and other major players tumbled following the Biden Administration's announcement regarding Medicare Advantage rates for 2025. The unexpected decision sent shockwaves through the industry, prompting a flurry of market activity and sparking concerns among investors.
Impact on Health Insurers:
The Biden Administration's announcement that final Medicare Advantage rates in 2025 will remain unchanged from initial plans in January dealt a blow to major health insurers, particularly UnitedHealth and Humana. Both companies, as leading Medicare Advantage players, experienced substantial declines in their stock prices, with Humana plunging 9.4% and UnitedHealth sinking 4% in premarket trading.
Market Response and Investor Sentiment:
The market response was swift and decisive, with other health insurers such as CVS Health and Cigna also witnessing notable retreats in their stock prices. CVS Health, a significant Medicare Advantage player, saw its stock retreat by 4% overnight, while Cigna experienced a 1.1% dip early Tuesday. Smaller players in the Medicare Advantage market, including Centene and Molina Healthcare, were not spared from the downturn, reflecting the broad impact of the announcement on the industry.
Technical Outlook and Bearish Trend:
UnitedHealth's stock is currently entrenched in a bearish trend, underscored by a Relative Strength Index (RSI) of 44.88 and trading below its respective Moving Averages (MA). This technical analysis further validates the bearish sentiment surrounding NYSE:UNH stock and highlights the challenges it faces in the current market environment.
Implications for the Healthcare Sector:
The Biden Administration's decision regarding Medicare Advantage rates in 2025 has far-reaching implications for the healthcare sector, potentially reshaping the competitive landscape and impacting revenue streams for major insurers. As companies navigate this period of uncertainty, strategic agility and resilience will be crucial in mitigating risks and seizing opportunities amidst evolving market dynamics.
UNH WEEKLY CHART United Health Care makes up 8.52% of XLV the health care ETF. If you go look at the ETF it's making new highs, while its second largest weighting is still trading in range. My question is how long does UNH continue trading in this sideways range its been in?
UNITED HEALTH Time to buy again?Last time we looked into United Health (UNH) we gave a strong buy signal (October 03 2023, see chart below), which turned out to be very successful:
After getting rejected on Resistance 3, the stock started to decline structurally within a Channel Down. It is a pattern similar to the Channel Down of November 2022 - March 2023, which was again formed after UNH got rejected within the 2-year Resistance Zone, like it happened this time.
There is a high symmetry these past 2 years within the Resistance and Support Zones, so we expect the price to act accordingly. As a result, having already formed a 1D Death Cross, we expect the price to make one last Low towards the Support Zone (as long as the 1D MA50 holds as Resistance) and then rebound, which is what took place on March 10 2023, above the 0.618 Fibonacci retracement level.
As a result, we will time our buy accordingly and target $517.00 (Fib 0.618). An additional buy signal would be if the 1W RSI makes a Double Bottom, similar again to March 10 2023.
-------------------------------------------------------------------------------
** Please LIKE 👍, FOLLOW ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! This is best way to keep it relevant, support us, keep the content here free and allow the idea to reach as many people as possible. **
-------------------------------------------------------------------------------
💸💸💸💸💸💸
👇 👇 👇 👇 👇 👇
UnitedHealth Weekly Wyckoff in progressWe can observe a weekly Wyckoff in place for UnitedHealth.
I have Two possible scenario
1) The price took the weekly liquidity (External Liquidity) and can now go Up until reaching "BC" at least
2) The price will go down and take frist the "STB" to make a "SPRING" and then will go UP until the "BC"
On my side I prefer to keep observing as the price can be slide in this kind of structure.
Healthy Returns: Going Long on United Health GroupThis is a trading idea with a medium-term horizon spanning a few weeks. We're observing United Health Group's stock stabilizing at a significant level on the daily chart. Concurrently, there's an emerging hidden bullish divergence in the OBV, albeit unconfirmed. Given UNH's price reaction at the support zone, we're considering a long trade. Our target is the low of the candle from January 11, 2024, which initiated the as yet unfilled gap. We're doing this because in overarching downtrends, prices tend not to fully close gaps but rather turn at the low of the candle before the gap. While we don't perceive United Health Group to be in a predominant downtrend, given the trade's highly favorable risk-reward ratio of 3:1, we're cautious about unnecessary risks.
UNH will recover from selloff on the Change Hlthcare cyberattackUNH has typically performed well in the market. Buying the dip on some just chance unfortunate news regarding the cyber attack that brought Change Healthcare down. I have held positions in UNH for over 15 years. This is a good one to buy and hold. Change my mind.
Own UNHUNH has been getting wrecked recently due to news, but this is still a powerhouse play when it comes to healthcare. I'm going long here.
Not financial advice, good luck to all :)
UnitedHealth: One Last Dip 💦UnitedHealth's share price has fallen sharply in recent weeks. However, it showed a reaction at the support level of $472.12 and has now risen a little. Our expectation is that it is currently working on the magenta wave (Z), the last sub-wave of the green wave (B). As part of this movement, the price should dip below the support level and form a low there. Only then should the price turn around.
UNH Stock tumble after report of antitrust investigationUnitedHealth Group ( NYSE:UNH ) finds itself navigating turbulent waters as it confronts both regulatory scrutiny and cybersecurity disruptions. The recent revelation of a U.S. Department of Justice antitrust investigation has sent shockwaves through the healthcare conglomerate, causing its shares to plummet by about 5%. This investigation, as reported by The Wall Street Journal, casts a shadow over UnitedHealth's ( NYSE:UNH ) acquisitions made through its health services arm, Optum, raising concerns about potential monopolistic practices and their impact on competition within the healthcare industry.
The timing couldn't be more precarious, as UnitedHealth ( NYSE:UNH ) grapples with the fallout from a cybersecurity attack on its Change Healthcare unit, which has led to an eight-day outage. The prolonged disruption has not only rattled investor confidence but has also triggered operational challenges for the conglomerate and its partners, including pharmacy chains like CVS Health.
Analysts are quick to underscore the significance of these developments. Scott Fidel, an analyst at Stephens, aptly describes it as a "tough past week of headlines for UnitedHealth." The market reaction has been swift and severe, with more than $25 billion wiped out from UnitedHealth's market value, exacerbating losses incurred earlier in the week.
The ramifications of the reported antitrust probe extend beyond UnitedHealth ( NYSE:UNH ), casting a shadow of uncertainty over its competitors. Humana and CVS Health, both with aspirations in caregiving akin to UnitedHealth's Optum arm, have witnessed declines in their respective stock prices, signaling investor apprehension about the potential ripple effects of the investigation.
Julie Utterback, an analyst at Morningstar, underscores the interconnectedness of the healthcare landscape, suggesting that the investigation could have implications for CVS and Humana, especially if it expands further.
The specifics of the investigation delve into the intricate relationships between UnitedHealthcare ( NYSE:UNH ) and Optum, probing into potential conflicts of interest and anti-competitive behaviors. Such scrutiny underscores the complexities inherent in the intersection of insurance and healthcare services, where conglomerates like UnitedHealth wield considerable influence.
Meanwhile, Change Healthcare continues to grapple with the aftermath of the cybersecurity incident, with disruptions expected to persist. The impact reverberates across the healthcare ecosystem, affecting not only UnitedHealth but also its partners and clients, including pharmacy chains reliant on its services.
As UnitedHealth ( NYSE:UNH ) navigates these challenges, stakeholders are left pondering the company's resilience and the broader implications for the healthcare industry. Will regulatory scrutiny force a reassessment of consolidation strategies? Can UnitedHealth ( NYSE:UNH ) effectively mitigate cybersecurity risks and restore trust in its operations?
Buy UNH | Profit Target @ $541UNH has been in a long-term uptrend channel for 6-10 years with steady growth. They're currently bouncing off the bottom of the trend channel within 1 ATR of their AVWAP (anchored from the prior high). The 3 ATR profit target at $541 is $14 above current price representing a 3:1 Risk/Reward. The next major resistance is at $558 ($17 above the target). Adding fuel to the fire, a 65-min TTM squeeze just fired! A March 5/35/540/545 call butterly can be had for .54, which would provide a max profit of $446 and max loss of $54. Alternatively, you could sell the 520 PUT for $5.55 (or maybe do both :)
Long-term position in UnitedHealth Group, Inc $UNHThis week, I entered a long-term position in UnitedHealth Group Inc NYSE:UNH
Timeframe: M
SL: ~$475
Target: ~$620
$UNH Measured MoveI think UNH will reclaim and resume the uptrend channel and this is a good RR long for a measured move.
UNH, the dominate health insurance market leader LONGAs shown on the 4H chart, UNH based on a long-term VWAP band setup, it as fiar value for the
first time since September. This dip is significant as price fell from a head and shoulders pattern
of three months duration. The candles in the past couple of days show the reversal at the
mean VWAP support. I have retrieved 60% out of a near term expiration call option. Some may
say this is simply a death cross on a pair of moving averages with a bit of correction on the
overall downtrend. I understand that point of view. Notwithstanding that perspective,
healthcare is expected to be an outperforming sector in 2024. UNH is on sale. As a healthcare
provider, it has paid me large sums in the historical past. I will take trades as described
in the text box on the chart. I believe buying out of the money and at a discount will be
a good strategy for this megacap moving forward.
UNH - where to take a long with the least risk?Joe, Selling the Jan 25 400 put was a great idea. If it returns to the 485 area I will join you on your idea.
I also may use the premium to finance buying a call.
UNH doji signaling a local low?NYSE:UNH dropped after reducing guidance in their earnings release, and then gapped down again today when NYSE:HUM missed estimates. These two stocks frequently respond to one another, creating fantastic trading opportunities if you have both on your watch list.
Todays candle is doji with relatively high volume, which is a decent reversal signal. Prior to today we can see 6 similar dojis during down trends for UNH since January 2022. 5 of them marked the local low. July 2023 was an exception that saw price fall by another 5% over 11 trading days before recovering.
The Top 3 Confirmation Signals for the Double Top Pattern
1 - Bearish Divergence
An indicator such as the RSI showing bearish divergence can confirm the weakening of the bullish trend.
2 - Volume Analysis
An increase in selling volume following the second peak reinforces the potential bearish reversal.
3 - Support Breakdown
A decisive breakdown below the support level confirms the validity of the double top pattern.
Watch this video to learn more
--
**Disclaimer:**
The information provided above is for educational and informational purposes only.
--
It does not constitute financial advice, and trading always involves
--
a risk of substantial losses, regardless of the margin levels
--
used. Before engaging in any trading activities, it is crucial to
--
conduct thorough research, consider your financial situation,
--
and, if necessary, consult with a qualified financial advisor. Past
--
performance is not indicative of future results, and market
--
conditions can change rapidly. Trading decisions should be made
--
based on careful analysis and consideration of individual
--
circumstances. The user is solely responsible for any decisions made
--
and should be aware of the inherent risks associated with trading in
--
financial markets.
UnitedHealth Group ($UNH) Shakes Investors with 4Q Earnings
UnitedHealth Group ( NYSE:UNH ) recently made headlines as it unveiled its fourth-quarter earnings, leaving investors with mixed sentiments. While the numbers beat estimates, concerns over rising medical costs and future pricing strategies have cast a shadow on the stock's performance. This article delves into the intricacies of NYSE:UNH 's financial report, analyzes the factors driving its market movement, and examines the outlook for the healthcare giant in the coming quarters.
Breaking Down the Numbers:
Analysts anticipated fourth-quarter earnings per share (EPS) of $5.98 for UNH, reflecting a 12% YoY increase. Surpassing expectations, UNH reported an impressive 15.4% growth in EPS, reaching $6.16 per share. Revenue also outpaced estimates, rising by 14.1% to $94.4 billion. However, the spotlight fell on the medical cost ratio, which climbed to 85 in Q4, exceeding analysts' projections. This ratio, representing the percentage of premiums spent on members' health needs, raised concerns about the sustainability of UNH's profit margins.
Factors Driving the Numbers:
NYSE:UNH attributed the elevated medical cost ratio to several ongoing factors, including the provision of outpatient care, primarily serving seniors, and the composition of its business mix. The company highlighted that coverage in government programs tended to incur higher costs compared to commercial coverage. Additionally, UNH acknowledged a $100 million unfavorable development in medical reserves during Q4, signaling potential challenges in managing future healthcare costs.
Outlook and Pricing Pressure:
Despite the strong performance, UNH maintained its full-year EPS guidance of $27.50 to $28, suggesting confidence in its ability to navigate challenges. However, analysts expressed concerns over the unexpected rise in the medical cost ratio, emphasizing the potential impact on pricing strategies in 2024. The company recognized a $100 million unfavorable development in medical reserves during Q4, marking the first negative revision since 4Q16. Analysts believe these details indicate heightened pressure on pricing in the coming years.
Stock Market Reaction:
Following the earnings release, UNH stock experienced a 3.65% decline to $520 in early Friday market action. The stock had previously shown signs of resilience by climbing 0.4% on Thursday, surpassing its 50-day and 10-week moving averages. Despite a consolidation period dating back to November 2022, UNH has struggled to gain significant momentum since April 2022. The relative strength line, tracking the stock's performance against the S&P 500 index, has been on a downward trend since November 2022.
Conclusion:
UnitedHealth Group's fourth-quarter earnings report has sparked a nuanced conversation among investors. While the company exceeded EPS and revenue expectations, concerns over the rising medical cost ratio and its impact on future pricing strategies have raised eyebrows. As UNH navigates these challenges, investors will closely monitor how the healthcare giant adapts its business model to maintain profitability in an evolving healthcare landscape.
UnitedHealth Pushes Highs Before EarningsUnitedHealth has consolidated for almost two years, and now some investors may expect its longer-term uptrend to continue.
The first pattern on today’s chart is the basing pattern over the course of 2023. Notice the lower lows in the first half, followed by higher lows in the second half. That may suggest buyers have regained control since the summer.
Second, the 50-day simple moving average (SMA) had a “golden cross” above the 200-day SMA in September. That can also reflect bullishness over the longer term.
Third, UNH recently bounced at its peak from July. Did old resistance become new support?
Fourth, the health insurer has remained below its record weekly close of $551.24. But this week could bring a catalyst for a potential breakout because earnings are due on Friday morning. (Notice how the stock jumped following its last two quarterly reports.)
TradeStation has, for decades, advanced the trading industry, providing access to stocks, options, futures and cryptocurrencies. See our Overview for more.
Important Information
Past performance, whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. There is a possibility that you may sustain a loss equal to or greater than your entire investment regardless of which asset class you trade (equities, options, futures or cryptocurrencies); therefore, you should not invest or risk money that you cannot afford to lose. Online trading is not suitable for all investors. View the document titled Characteristics and Risks of Standardized Options at www.TradeStation.com . Before trading any asset class, customers must read the relevant risk disclosure statements on www.TradeStation.com . System access and trade placement and execution may be delayed or fail due to market volatility and volume, quote delays, system and software errors, Internet traffic, outages and other factors.
Securities and futures trading is offered to self-directed customers by TradeStation Securities, Inc., a broker-dealer registered with the Securities and Exchange Commission (“SEC”) and a futures commission merchant licensed with the Commodity Futures Trading Commission (“CFTC”). TradeStation Securities is a member of the Financial Industry Regulatory Authority, the National Futures Association (“NFA”), and a number of exchanges. TradeStation Crypto, Inc. offers to self-directed investors and traders cryptocurrency brokerage services under federal and state money services business/money-transmitter and similar registrations and licenses.
TradeStation Securities, Inc., TradeStation Crypto, Inc., and TradeStation Technologies, Inc. are each wholly owned subsidiaries of TradeStation Group, Inc., all operating, and providing products and services, under the TradeStation brand and trademark. TradeStation Crypto, Inc. offers to self-directed investors and traders cryptocurrency brokerage services. It is neither licensed with the SEC or the CFTC nor is it a member of NFA. When applying for, or purchasing, accounts, subscriptions, products and services, it is important that you know which company you will be dealing with. Visit www.TradeStation.com for further important information explaining what this means.
UnitedHealth Group Inc. (UNH) Trading Idea for 28/12/2023Healthcare provider UnitedHealth Group Inc. is diversifying its business. Following the acquisition of the home health services company LHC Group for $5.4 billion earlier this year, the company also has plans to acquire another home healthcare company, Amedisys, for $3.3 billion. These strategic investments will help strengthen UnitedHealth Group's position in the rapidly expanding senior care market.
Therefore, today, we direct our attention to the UnitedHealth Group Inc. (NYSE: UNH) stock chart.
On the D1 timeframe, support has formed at 515.87, with resistance at 549.42. A relatively wide channel has developed within the descending trend. Considering the prevailing investor sentiment amid the US Federal Reserve's softened rhetoric, the trend for this asset may change upward if the quotes solidify above the 528.65 level.
On the H1 timeframe, if there is a rebound from the level of 515.87, the short-term target for the price increase can be set at 528.68, while in the medium term, it could hover around 554.09.
—
Ideas and other content presented on this page should not be considered as guidance for trading or an investment advice. RoboMarkets bears no responsibility for trading results based on trading opinions described in these analytical reviews.
The material presented and the information contained herein is for information purposes only and in no way should be considered as the provision of investment advice for the purposes of Investment Firms Law L. 87(I)/2017 of the Republic of Cyprus or any other form of personal advice or recommendation, which relates to certain types of transactions with certain types of financial instruments.
Risk Warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67.85% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
